FIELD: medicine, biotechnology. SUBSTANCE: invention proposes the substance that is able to modify functions of peripheral afferent system and method of its use. Invention ensures to diminish the pain syndrome in acute and chronic diseases. EFFECT: enhanced effectiveness of substance, improved method of use. 36 cl, 8 dwg, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FUSION PROTEINS AND METHODS OF TREATMENT, PREVENTION OR ALLEVIATION OF PAIN | 2013 |
|
RU2652954C2 |
| THERAPEUTIC FUSION PROTEINS | 2012 |
|
RU2651492C2 |
| BIOPREPARATIONS COMPOSITIONS FOR INTRAVESICAL INSTILLATION | 2015 |
|
RU2720991C2 |
| RECOMBINANT PROTEIN EXPRESSION IN DOUBLE-STRAND C FORM | 2006 |
|
RU2412253C2 |
| CELLULAR VAMP CLEAVAGE ASSAY | 2017 |
|
RU2807994C2 |
| METHOD OF DETERMINING THE ACTIVITY OF BOTULINUM TOXIN USING CELLS | 2019 |
|
RU2803123C2 |
| HYBRID NEUROTOXINS | 2017 |
|
RU2782382C2 |
| SUPPRESSION OF ALLODYNIA INDUCED BY BONE CANCER | 2019 |
|
RU2791640C2 |
| GANGLIOSIDES FOR STANDARDIZING AND INCREASING CELL SENSITIVITY TO BOTULINUM NEUROTOXINS IN IN VITRO TEST SYSTEMS | 2015 |
|
RU2694191C2 |
| COMPOSITIONS AND METHODS FOR TOXIGENIC TESTING | 2012 |
|
RU2616281C2 |
